Scientist Solutions: International Life Science Community By Scientists For Scientists
Home » Societies » The Biotech Research Society of India Forum

The Biotech Research Society of India Forum

Thanks to our sponsors who make this site possible
Welcome Members and guests. Our Forum is brought to you through our partnership with Scientist Solu- which manages these pages to promote the free exchange of useful scientific information. We
encourage you to dive in and join the conversation!

How do I use this forum?
Registered members can create new topics and reply to topics from other users. To learn more about s-
uccessful posting in the forums Click Here. Subscribing to Society Sub-forums will keep you informed
and involved.
Disclaimer - The The Biotech Research Society of India Society supports the free exchange of scientific information, but is not responsible or liable for comments made in public forums such as this one. Topics and posts deemed unsuitable will be moderated and removed.

The Biotech Research Society of India Subforums

RSS Feed
Sub-forumsTopics  Replies  ViewsLast Post

Strategies to Identify Drug Targets/Biomarkers

22 23 36098

Urgent Dilution problem! Please hel ...

by Saluferkimo
May 21, 2015, 15:24 PM

Target Validation Techniques

Target Validation Techniques
9 9 24633


by skarthikumar
Nov 09, 2012, 11:02 AM


Extent and rate of absorption, distribution, metabolism and excretion ( ADME)
18 46 53409


by Debbie Reed Bietz
Jun 25, 2012, 11:25 AM

Bioprocessing/Scale Up and Isolation

Fermentation, cell culture, expression, and recovery
22 27 37606

isolating dna from spotted on filte ...

by Pippuri
May 04, 2015, 16:26 PM

Good Manufacturing/Validation Practice (GMP/GVP)

Control and management
24 51 51927

Performance Qualification (PQ) of L ...

by Eibhor
Aug 17, 2015, 21:01 PM


Pharmacology equipment
18 49 47343

How to choose your system Fiber opt ...

by Idealphotonics
Oct 05, 2015, 6:41 AM

Assay Development & Protocols

Also, remember to visit the protocols tab on the homepage toolbar
48 46 59940

Xanthine Oxidase Inhibitory Assay

by Paye
Feb 27, 2012, 20:34 PM

Society Overview

The aims & objectives of the Biotech Research Society [BRSI] are:
  • To promote the R&D in biotechnology in India
  • To bring interaction between the academic institutes and the biotech industries, interact with the industries and help them in resolving their problems, as well make them aware with the latest developments in the biotech sector
  • To provide and arrange the training in biotechnology, dissemination of biotech knowledge through the organization of the lectures, seminars and symposia on the scientific programmes and societal missions.

Contact Society Forum Organizer
Society Organizer: Ashok Pandey

Click here to
Become a member & join our
community (It's easy & free)
Already a member? Please log in
User Name  
Forget Password?
News Feeds from
BioTech News
Biotech news continually updated from thousands of sources around the net.

Other equities analysts have also issued reports about the company. Guggenheim initiated coverage on Biogen in a report on Monday, October 23rd.

To celebrate, PetSmart is having a grand opening e... )--While the nation celebrates Random Acts of Kindness Day this weekend, Kirby, the charming hero known for his powerful Copy Abilities, is preparing a celebration of ... )--Second Sight Medical Products, Inc. , a developer, manufacturer and marketer of implantable visual prosthetics that ... )--Elliott Advisors Limited , which advises funds that collectively hold an economic interest in NXP Semiconductors N.V. --The "China: Soda Ash - Market Report - Analysis And Forecast To 2025" report has been added to's offering.

Stocks closed out their strongest week in five years Friday and have now recovered more than half of the losses they suffered in a plunge at the beginning of the month.

Southern states have been especially hard hit, with 24 of the pediatric deaths taking place from Mississippi to North Carolina. ATLANTA Another 22 children have died from the flu in the United States, the Centers for Disease Control and Prevention reported Friday.

In this Friday, Feb. 9, 2018 file photo, lab technologist Sharda Modi tests a patient's swab for a flu infection at Upson Regional Medical Center in Thomaston, Ga. On Friday, Feb. 16, 2018, a report released by the Centers for Disease Control and Prevention shows the flu season may finally be leveling off.

The brokerage presently has a $380.00 price objective on the biopharmaceutical company's stock. Zacks Investment Research 's price target indicates a potential upside of 14.05% from the stock's current price.

Loudon Investment Management LLC lifted its stake in Pfizer Inc. by 29.1% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 64,787 shares of the biopharmaceutical company's stock after buying an additional 14,594 shares during the period.

Secretary of Health and Human Services Alex Azar said Thursday that he would allow his department to conduct research into the causes of gun violence, a major Democratic priority. Democrats on Thursday pushed for lifting a provision that restricts the Centers for Disease Control and Prevention from conducting research into gun violence as part of their response to the mass shooting at a Florida school on Wednesday.

Stocks are rising for a fifth day despite rising producer prices and jobless claims that remained near a 45-year low. The S&P 500 has risen 0.5% to 2712.46 at 9:43 a.m. today, while the Dow Jones Industrial Average has climbed 195.5 points, or 0.8%, to 25,089.02.

This year's vaccines reduce flu cases by about one third, but effectiveness against the most common strain causing the most misery is lower. Flu viruses are quick-change artists.

U.S. stocks are rising Thursday as investors continue to snap up shares of companies that do better in times of faster economic growth, such as industrial and technology companies and banks. A round of solid results from companies including Cisco Systems are also sending the market higher.

This Aug. 24, 2015, file photo shows the New York Stock Exchange. The U.S. stock market opens at 9:30 a.m. EST on Thursday, Feb. 15, 2018.

Victory Capital Management Inc. cut its position in shares of Alexion Pharmaceuticals, Inc. by 6.1% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 113,701 shares of the biopharmaceutical company's stock after selling 7,441 shares during the quarter.

Bristol-Myers Squibb Co will pay Nektar Therapeutics $1.85 billion for a global development and profit-sharing deal on a promising Nektar cancer drug, the companies announced on Wednesday. In one of the largest single-drug collaboration deals ever, Nektar will receive $1 billion in cash upfront and Bristol-Myers will purchase about 8.28 million Nektar shares at $102.60 per share, or an equity stake of just under 5 percent of the company.

Progenics Pharmaceuticals, Inc. saw unusually large options trading on Tuesday. Investors bought 2,342 call options on the company.

Melania Trump has brought some Valentine's Day cheer to children receiving medical treatment at a private facility on the campus of the National Institutes of Health. She helped one group of kids decorate heart-shaped cookies with white frosting and sprinkles.

The move means Banyan Biomarkers can commercialize its test, giving the San Diego-based company an edge in the biotech industry's race to find a way to diagnose concussions. The test doesn't detect concussions, but instead measures two proteins present in brain cells.

Thank You to Our Sponsor